Aurobindo Pharma Faces Significant Regulatory Hurdle as USFDA Flags Telangana Facility as 'Official Action Indicated'
Lupin's Pithampur Unit 2 Under Scrutiny: USFDA Issues Form 483 with Four Key Observations